Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Natalia Perekhvatova

Natalia Perekhvatova

individual
Ecosystem influencer

About

Natalia Perekhvatova is the CEO of Mitotech S.A., a Luxembourg-based clinical-stage biotechnology company developing mitochondria-targeted drugs for age-related disorders, especially in ophthalmology. Mitotech says she joined as Chief Financial Officer in 2010 and helped lead the company from drug discovery into clinical-stage development. Before Mitotech, she held senior roles at Citigroup and Amadeus and earned an MBA from INSEAD.

Areas of interest

longevitybiotechophthalmologymitochondrial biologyage-related disordersdrug developmentclinical trialsneurodegenerative disease